Vasocure is a vascular therapeutics enterprise in clinical development that uses a peptide to treat neointimal disease and atherosclerosis. They're a pharmaceutical firm with nephrology, cardiology, and oncology candidates. Their precision medicine approach to creating pedifin will employ a predictive clinical strategy to identify the optimumtreatment delivery. They believe a new approach is needed, and the pedifin medication treats neointimal illness and gives hope to people with kidney failure.

Biotechnology

Clinical Trials

Health & Wellness

Health Care

Vasocure

Vasocure's headquarters in New York, NY, United States

Moro Salifu

Yigal Ehrlich

Elizabeth Kornecki

Anna Babinska

Aditya Mattoo

Vasocure

Org chart

Board & advisors

Teams

Offices

Similar companies